Events

Join the CTN Translation & Implementation SIG for their next meeting, July 21, 2026, 9-10am PT. Drs. Sabeeh Baig, Jeremiah Bertz, and Landhing Moran will describe the methods and findings from their comprehensive portfolio analysis of all studies within the CTN approved from 2000 through 2024. Their presentation will highlight scientific areas in the CTN portfolio, portfolio growth trends, and research impact through this period. The presentation will conclude with a discussion of the CTN's achievements and the strengths of its trial infrastructure. Read more about the speakers Contact Elena Rosenberg-Carlson at rosenbee@stanford.edu for the meeting link or to join the CTN T&I email list.

The Harm Reduction International Conference is convened by Harm Reduction International in a different city every two years. Over four days of presentations, workshops, films, networking events and more, the conference provides a dynamic forum to share the latest research and discussions on best practice in drug use, harm reduction and human rights and attracts a diverse group of over 1,000 delegates and speakers including front-line health workers, academics, researchers, policy makers, politicians, UN representatives, people who use drugs, sex workers and people working in the criminal legal system.

Join the Health Systems Node for this upcoming event at which Caitlin Ryus, MD, MPH, Assistant Professor in the Department of Emergency Medicine at Yale School of Medicine, will discuss a Connecticut-based study that links administrative data from homelessness services and electronic health records to examine the relationship between rapid rehousing and substance-related emergency department visits. Connect: Microsoft Teams. Meeting ID: 250 658 877 216 6 | Passcode: B8jq2m9A.

Join host Ohio Valley Node PI T. John Winhusen, PhD, this summer for the University of Cincinnati/UC Health Addiction Center’s webinar series! This series will highlight cutting-edge UC addiction research and UC-community collaborations focused on prevention and treatment. The third and final installment of this series will feature Corey J. Hayes, PharmD, PhD, MPH (U. Arkansas) and Daniel Bebo, MD (U. Cincinnati) talking about personalized medicine for opioid use disorder. Register here.

Join over a thousand fellow addiction professionals at the Sheraton Kansas City Hotel at Crown Center in Kansas City, MO, for the 2026 NAADAC Annual Conference (theme: Empower 2026). This immersive educational experience will provide you with addiction-specific CEs, fantastic networking opportunities, and the chance to learn about the latest advancements in the field. Join us in August and take part in interactive workshops, panel discussions, pre- and post-conference sessions, poster presentations, an exhibit hall, special events, networking opportunities, and so much more! Registration is now open!

Join the Health Systems Node for this upcoming session, in which Tessa Matson, PhD, MPH, Collaborative Scientist at Kaiser Permanente Washington Health Research Institute, will present findings from a CTN implementation trial on factors that distinguished clinics that successfully increased opioid use disorder treatment from those that did not. Connect: Microsoft Teams. Meeting ID: 250 658 877 216 6 | Passcode: B8jq2m9A.

CME accreditation for providers pending; a certificate of attendance will be available for all attendees (in-person or virtual) Register here (for in-person and virtual attendance) | View program In a recent survey of Washington State healthcare providers about cannabis negative effects, 70% of respondents reported seeing cases of severe abdominal pain, nausea, retching, and relentless vomiting among people reporting heavy cannabis use. This cluster of symptoms is now recognized as Cannabinoid Hyperemesis Syndrome (CHS). As CHS becomes more visible in clinical settings, providers are left navigating care without clear understanding or guidance. At the same time, while 1 in 10 Washingtonians who consumed cannabis in the last year report vomiting and nausea due to their cannabis use2, many people remain skeptical that the condition exists at all, creating challenges for treatment, prevention and health education. To better understand these dynamics, we are making CHS the focus of this year’s ADAI Symposium. Join the University of Washington's Addictions, Drug & Alcohol Institute (home of the CTN Pacific NW Node) on September 18, 2026, to learn more about:   CHS prevalence among adolescents and adults in U.S. emergency departments CHS in Washington State CHS as a contested disease and implications for health communication CHS presentation, treatment, and management across settings Policy recommendations to prevent CHS increase Improving care for individuals with CHS

The Greater Southern California Node and its Pacific Southwest Addiction Technology Transfer Center (PSATTC) partners would like to invite you to Guam's 7th Annual Behavioral Behavioral Health & Addictions Virtual Conference. This FREE two-day virtual conference held in recognition of National Recovery Month will feature 4 plenary presentations and 4 breakout sessions, offering 8 concurrent workshop tracks. Whether you are looking to strengthen your clinical practice, learn about emerging trends, or discover innovative approaches to providing care, this conference offers valuable education and practical strategies to support your work. Sponsored by the Guam Behavioral Health and Wellness Center and the Pacific Southwest ATTC.

The Addiction Health Services Research (AHSR) conference brings together researchers, policymakers, and treatment providers to solve the problems of inequity, access, effectiveness, and implementation of addiction services.

As the largest public health gathering of the year, APHA’s Annual Meeting and Expo convenes approximately 11,000 public health professionals and partners from around the world. Join APHA for this can’t-miss opportunity to make lasting connections and learn from exhibitors, peers and today’s leaders. Early bird rates available until September 16, 2026. View program | Register here

AMERSA — the Association for Multidisciplinary Education and Research in Substance Use and Addiction — celebrates its 50th Annual Conference November 12–14, 2026 in Washington, DC. The program brings together physicians, nurses, pharmacists, social workers, counselors, researchers, peer recovery professionals, and people with lived and living experience with plenaries on emerging drugs of concern, contingency management, cannabis and psilocybin regulation, DC/Maryland policy innovation, and the evidence on GLP-1s. Early bird registration is open through August 31.  

This event provides the latest scientific developments in substance use disorders and co-occurring mental health disorders for psychiatrists, primary care physicians, and allied health professionals. The goal of the conference is to recognize emerging issues and trends in Addiction Psychiatry and be on the forefront of the diagnosis and treatment of substance use disorders and co-occurring psychiatric disorders.